ENvue Medical, Inc. — Form 8-K
Filed August 31, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
ENvue Medical (NASDAQ: FEED), a $7.3M market-cap medical device company, executed a 1-for-12 reverse stock split approved by stockholders on August 14, 2026, effective September 1, 2026. Outstanding shares reduced from 11,084,616 to approximately 923,718 shares; authorized shares remain 40,000,000. No fractional shares issued; fractional holdings rounded up per shareholder. Exchange agent: VStock Transfer, LLC. No change to ownership percentages, voting rights, or par value.
Why this rating
Reverse splits are routine capital structure events for small-cap companies facing low share prices; no business fundamentals altered, no financing, no strategic change.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.